Patent ID: 9517240
Filing Date: 2016-12-13
CPC Classification: A61K

Claim Text:
1. A method for delaying the onset of progesterone receptor related cancers comprising: a) providing a human subject with a breast cancer gene 1 (BRCA1) mutation that is progesterone receptor related and a p53 mutation, wherein said subject has been diagnosed as possessing said BRCA1 mutation; b) providing a progesterone receptor antagonist, wherein said progesterone receptor antagonist comprises 17α-acetoxy-11β-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione (CDB-2914), and c) treating said subject with said progesterone receptor antagonist thereby preventing or delaying the onset of said progesterone receptor related cancer.